Grail Cancer Detection Blood Test Services
-
Manufactured by Grail, Inc.based in USA
Evaluation of a New Blood Test for Detecting Multiple Types of Cancer Early. The SUMMIT Study is a prospective, observational, longitudinal, cohort study being conducted in London in the United Kingdom. It is designed to enroll approximately 25,000 men and women age 50 to 77 years who do not have a cancer ...
-
Manufactured by Grail, Inc.based in USA
detection of multiple cancer types. Participants completed a health questionnaire and provided a blood sample around the time of their screening mammogram and will be followed for up to five years to capture clinical outcome data, including cancer ...
-
Manufactured by Grail, Inc.based in USA
of cancer through a single blood draw, with a very low false positive rate. PATHFINDER is the first time GRAIL’s multi-cancer early detection test will be used to return results to healthcare providers and communicated to participants to help guide appropriate diagnostic workup for more than 50 ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you